Glycyrrhizin is a chemical which is found in the roots of Glycyrrhiza glabra (liquorice), the plants belongs to legume family. Glycyrrhiza glabra is native to the regions of Asia Pacific and Western Europe. It’s been ages that glycyrrhizin is used as an herbal medicine in china. Glycyrrhizin is also used as a sweet flavoring agent in sweets, toothpaste, chewing gums soft drinks and beers. In various parts of Asia pacific glycyrrhizin is also used as an ingredient in hot herbal tea. It is said to be much sweeter than the regular sugar we consume in our daily life. Research has found that glycyrrhizin has a glucocorticoid properties in it, similar to steroids. Glycyrrhizin has positive as well as adverse health effects on human body. Glycyrrhizin is also used as a gelling agent in food and cosmetic products.
Glycyrrhizin market is segment on the basis of application, distribution channel and region. On the basis of application the market is segmented into pharmaceuticals, food & beverage and cosmetic industries. Among all these segment pharmaceuticals is expected to grow to a great extent in the forecast period, as there is a humongous use of glycyrrhizin in treating various diseases. The demand for glycyrrhizin is also more as it is used as a sweetening agent in the food and beverage industry. On the basis of distribution channel the market is segmented into upermarkets/hypermarkets, medical stores and online stores. Medical stores is anticipated to hold a relatively higher share in the glycyrrhizin market, followed by supermarkets/hypermarkets. On the basis of region the glycyrrhizin market is segmented into North America, Latin America, Europe, Asia Pacific & Japan and MEA.
Market Regional Outlook:
Regional segment for the market of glycyrrhizin is divided into five different regions: North America, Latin America, Europe, Asia Pacific & Japan and MEA. Among these segment Asia Pacific is expected to be the leader of glycyrrhizin market share globally, and is expected to be dominant in the forecaster period. In Asia Pacific region the countries like china and japan are the key market for glycyrrhizin, Uzbekistan is also generating high revenue as the country is one of the largest producers of glycyrrhizin. In terms of revenue Europe is the expected to be the second leading contributor in the glycyrrhizin market, followed by North America.
The rising awareness about the medical benefits glycyrrhizin among the consumers is driving the market of glycyrrhizin. The market of glycyrrhizin is also increasing due to the strong increase of disposable personal income along with rising population and the multiple use of glycyrrhizin in the food & beverage and pharmaceutical industry. With the arrival of new market players in the global market is anticipated to boost the growth of glycyrrhizin market globally during the forecast period. Glycyrrhizin offers a lot of health benefits such as it helps in the prevention of peptic ulcers which cause abdominal pain and loss of appetite, acts as a good anti-bacterial agent, its stops the fat accumulation in the body and to lose weight. Glycyrrhizin is also used to cure long term chronic disease like hepatitis C. The market of glycyrrhizin is also expected to grow because of the growing demand of glycyrrhizin in the Asia Pacific region due to the wide range of application in the cosmetic industry. Along with the health benefits associated with glycyrrhizin, there are some adverse effects which will hinder the growth of the glycyrrhizin market such as, it induces the blood pressure which may cause some adverse effect, loss of potassium from the blood occurs which may cause muscle weakness. Moreover, consumption of glycyrrhizin by a pregnant woman may lead to premature delivery of the baby.
Market Key Players:
Some of the key players in glycyrrhizin market are Minophagen Pharmaceutical Co Ltd., Douglas Labs, Shaanxi Fujie Pharmaceutical Co. Ltd, FAME Pharmaceuticals Industry Co., Ltd., MAFCO Worldwide LLC, Fanzhi Group, Gansu Yalan Pharmaceutical Co., Ltd ,Greenline Biotech Co., LTD, Ruihong Bio-technique, ELION Group Limited., Hunan Dinuo Pharmaceutical Co., Ltd., MARUZEN PHARMACEUTICALS CO., LTD., Xinjiang TIANSHAN Pharmaceuticals Industry Co.,Ltd, Qingdao Taitong Pharmaceutical Co., Ltd. CokeyCo.,Ltd
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.